Position in LH
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,616,200
+$602,848 QoQ
Shares Held
12,915
+14.4% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#287
of 1,040 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NEOS Investment Management LLC holds $114,352,841 across 11 Diagnostics & Research names. LH ranks #9 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
60,354 | $31,772,759 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
61,295 | $30,730,861 | |
| 3 | DHR |
Danaher Corp /De/
|
102,582 | $19,539,819 | |
| 4 | A |
Agilent Technologies, Inc.
|
46,201 | $6,136,878 | |
| 5 | WAT |
Waters Corp /De/
|
15,252 | $5,720,110 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
27,361 | $5,286,692 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
3,172 | $4,052,261 | |
| 8 | DGX |
Quest Diagnostics Inc
|
17,210 | $3,647,659 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,616,200 | 12,915 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,013,352 | 11,294 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $689,919 | 2,750 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $786,256 | 2,739 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $255,421 | 973 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $225,058 | 967 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $221,523 | 966 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $217,446 | 973 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||